Production (Stage)
CureVac N.V.
CVAC
$5.57
-$0.03-0.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 566.88M | 579.37M | 332.71M | 71.21M | 63.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 566.88M | 579.37M | 332.71M | 71.21M | 63.92M |
| Cost of Revenue | 69.89M | 114.23M | 150.77M | 164.44M | 148.75M |
| Gross Profit | 496.99M | 465.14M | 181.94M | -93.23M | -84.83M |
| SG&A Expenses | 76.95M | 80.43M | 90.76M | 91.82M | 99.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -8.35M | -12.32M | -16.58M | -12.36M | -13.26M |
| Total Operating Expenses | 313.43M | 347.92M | 374.57M | 369.64M | 364.29M |
| Operating Income | 253.45M | 231.44M | -41.86M | -298.44M | -300.38M |
| Income Before Tax | 228.42M | 206.91M | -63.16M | -298.64M | -295.31M |
| Income Tax Expenses | 30.79M | 31.06M | 16.99M | 2.31M | 935.40K |
| Earnings from Continuing Operations | 197.63 | 175.85 | -80.15 | -300.95 | -296.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 197.63M | 175.85M | -80.15M | -300.95M | -296.25M |
| EBIT | 253.45M | 231.44M | -41.86M | -298.44M | -300.38M |
| EBITDA | 266.80M | 245.26M | -25.00M | -276.69M | -278.00M |
| EPS Basic | 0.88 | 0.78 | -0.36 | -1.34 | -1.32 |
| Normalized Basic EPS | 0.74 | 0.68 | -0.08 | -0.79 | -0.79 |
| EPS Diluted | 0.88 | 0.78 | -0.36 | -1.34 | -1.32 |
| Normalized Diluted EPS | 0.74 | 0.68 | -0.08 | -0.79 | -0.79 |
| Average Basic Shares Outstanding | 898.37M | 897.57M | 897.41M | 896.87M | 896.44M |
| Average Diluted Shares Outstanding | 898.37M | 897.57M | 897.41M | 896.87M | 896.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |